Compare Stocks

Aztlan Global Stock Selection DM SMID ETF NYSEARCA:AZTD

The Aztlan Global Stock Selection Dm SMID ETF (AZTD) is an exchange-traded fund that mostly invests in extended market equity. The fund tracks an equal-weighted index of 27 mid- and small-cap stocks from developed markets, selected based on six factors: value, cashflow, capital structure, growth, EPS revisions, and price momentum. AZTD was launched on Aug 18, 2022 and is managed by Aztlan.

Leuthold Select Industries ETF NYSEARCA:LST

The Leuthold Select Industries ETF (LST) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking capital appreciation by broadly investing in US equity securities. The selection process utilizes a quantitative approach that focuses on shifts in industry groups LST was launched on Jan 21, 2025 and is issued by Leuthold.

Nightstar Therapeutics NASDAQ:NITE

Nightstar Therapeutics plc, a clinical-stage gene therapy company, focuses on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases in the United Kingdom. The company's lead product candidate is NSR-REP1, a candidate that is in phase 3 clinical development for the treatment of patients with choroideremia. It is also developing NSR-RPGR, a candidate that is in Phase 1/2 clinical trials for the treatment of patients with X-linked retinitis pigmentosa, an inherited X-linked recessive retinal disease; and NSR-BEST1, a candidate that is in preclinical development stage for the treatment of best vitelliform macular dystrophy. In addition, the company is developing NSR-ABCA4, a candidate that is in preclinical development stage for the treatment of Stargardt disease. The company was founded in 2013 and is headquartered in London, the United Kingdom.

ELEMENTS Linked to the Morningstar Wide Moat Focus Total Return Index NYSEARCA:WMW